<DOC>
	<DOCNO>NCT03103256</DOCNO>
	<brief_summary>The purpose study determine superiority YHP1701 compare monotherapy patient hypertension primary hypercholesterolemia .</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy Safety YHP1701</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Both man woman 19 year old Patient dyslipidemia hypertension sSBP difference ≥20 mmHg sDBP difference ≥10 mmHg A history cardiovascular disease Rhabdomyolysis , myopathy Hypertension hypercholesterolemia due secondary cause Uncontrolled diabetes Evidence hepatic renal disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>